Ca2+/calmodulin-based signalling in the regulation of the muscle fibre phenotype and its therapeutic potential via modulation of utrophin A and myostatin expression

被引:43
作者
Michel, Robin N.
Chin, Eva R.
Chakkalakal, Joe V.
Eibl, Joe K.
Jasmin, Bernard J.
机构
[1] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada
[2] Concordia Univ, Dept Exercise Sci, Montreal, PQ H4B 1R6, Canada
[3] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada
[4] Pfizer Global Res & Dev, Dept Cardiovasc & Metab Dis, Groton, CT 06340 USA
[5] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada
[6] Univ Ottawa, Fac Med, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada
关键词
calcineurin; CaMK; gene expression; muscular dystrophy; activity;
D O I
10.1139/H07-093
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Ca2+ signalling plays an important role in excitation-contraction coupling and the resultant force output of skeletal muscle. It is also known to play a crucial role in modulating both short- and long-term muscle cellular phenotypic adaptations associated with these events. Ca2+ signalling via the Ca2+/calmodulin (CaM)-dependent phosphatase calcineurin (CnA) and via Ca2+/CaM-dependent kinases, such as CaMKl and CaMKII, is known to regulate hypertrophic growth in response to overload, to direct slow versus fast fibre gene expression, and to contribute to mitochondrial biogenesis. The CnA- and CaMK-dependent regulation of the downstream transcription factors nuclear factor of activated T cells (NEAT) and myocyte-specific enhancer factor 2 are known to activate muscle-specific genes associated with a slower, more oxidative fibre phenotype. We have also recently shown the expression of utrophin A, a cytoskeletal protein that accumulates at the neuromuscular junction and plays a role in maturation of the postsynaptic apparatus, to be regulated by CnA-NFAT and Ca2+/CaM signalling. This regulation is fibre-type specific and potentiated by interactions with the transcriptional regulators and coactivators GA binding protein (also known as nuclear respiratory factor 2) and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha. Another downstream tat-get of CnA signalling may be myostatin, a transforming growth factor-beta family member that is a negative regulator of muscle growth. While the list of the downstream targets of CnA/NFAT- and Ca2+/CaM-dependent signalling is emerging, the precise interaction of these pathways with the Ca2+-independent pathways p38 mitogen-activated protein kinase, extracellular signal-regulated kinases l and 2, phosphoinositide-3 kinase, and protein kinase B (Akt/PKB) must also be considered when deciphering fibre responses and plasticity to altered contractile load.
引用
收藏
页码:921 / 929
页数:9
相关论文
共 43 条
[1]   Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice [J].
Akimoto, T ;
Ribar, TJ ;
Williams, RS ;
Yan, Z .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (05) :C1311-C1319
[2]   Animal models for muscular dystrophy: valuable tools for the development of therapies [J].
Allamand, V ;
Campbell, KP .
HUMAN MOLECULAR GENETICS, 2000, 9 (16) :2459-2467
[3]   Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction [J].
Angus, LM ;
Chakkalakal, JV ;
Méjat, A ;
Eibl, JK ;
Bélanger, G ;
Megeney, LA ;
Chin, ER ;
Schaeffer, L ;
Michel, RN ;
Jasmin, BJ .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2005, 289 (04) :C908-C917
[4]   Signaling pathways in skeletal muscle remodeling [J].
Bassel-Duby, Rhonda ;
Olson, Eric N. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :19-37
[5]   Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype [J].
Bigard, X ;
Sanchez, H ;
Zoll, J ;
Mateo, P ;
Rousseau, V ;
Veksler, V ;
Ventura-Clapier, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) :19653-19660
[6]   Function and genetics of dystrophin and dystrophin-related proteins in muscle [J].
Blake, DJ ;
Weir, A ;
Newey, SE ;
Davies, KE .
PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :291-329
[7]   Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[8]   A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy [J].
Burton, EA ;
Tinsley, JM ;
Holzfeind, PJ ;
Rodrigues, NR ;
Davies, KE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :14025-14030
[9]   Targeted inhibition of Ca2+/calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle [J].
Chakkalakal, JV ;
Michel, SA ;
Chin, ER ;
Michel, RN ;
Jasmin, BJ .
HUMAN MOLECULAR GENETICS, 2006, 15 (09) :1423-1435
[10]   Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies [J].
Chakkalakal, JV ;
Thompson, J ;
Parks, RJ ;
Jasmin, BJ .
FASEB JOURNAL, 2005, 19 (08) :880-891